Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of lipid diseases.

Human genomics - 1 Jan 2004

Ordovas Jose M

Abstract excerpt

The genetic basis for most of the rare lipid monogenic disorders have been elucidated, but the challenge remains in determining the combination of genes that contribute to the genetic variability in lipid levels in the general population; this has been estimated to be in the range of 40-60 per cent of the total variability. Therefore, the effect of common polymorphisms on lipid phenotypes will be greatly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to Arteriosclerosis
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol

Share to Hyperlipidemias

Share to Hypolipidemic Agents

Share to Lipids

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 15601539
DOI: 10.1186/1479-7364-1-2-111
PMCID: PMC3525073

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of lipid diseases.PMID 15601539Read ↗

Genetic determinants of lipid homeostasis.Semantic proximity Read ↗

Pharmacogenomics of blood lipid regulation.Semantic proximity Read ↗

Genetics of lipid disorders.Semantic proximity Read ↗

Genetics and personalized medicine--a role in statin therapy?Semantic proximity Read ↗

Nutrigenetics of the lipoprotein metabolism.Semantic proximity Read ↗

Defining the spectrum of alleles that contribute to blood lipid concentrations in humans.Semantic proximity Read ↗

Gene–gene and gene–environment interactions defining lipid-related traitsSemantic proximity Read ↗

Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial HypercholesterolemiaSemantic proximity Read ↗

Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.Semantic proximity Read ↗

Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.Semantic proximity Read ↗

Genetic variation and lipid metabolism: modulation by dietary factors.Semantic proximity Read ↗

Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.